Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia

INTRODUCTION: Guidelines for the use of cerebrospinal fluid (CSF) biomarkers in the diagnosis of Alzheimer's disease (AD) establish that each laboratory must use internally qualified cutoff values. We determined the concentrations of biomarkers that discriminate cases from controls and combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Forlenza, Orestes V., Radanovic, Marcia, Talib, Leda L., Aprahamian, Ivan, Diniz, Breno S., Zetterberg, Henrik, Gattaz, Wagner F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
CSF Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879480/
https://www.ncbi.nlm.nih.gov/pubmed/27239524
http://dx.doi.org/10.1016/j.dadm.2015.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879480/
https://www.ncbi.nlm.nih.gov/pubmed/27239524
http://dx.doi.org/10.1016/j.dadm.2015.09.003

Ejemplares similares